Bourgonje, Arno R.
Hörstke, Nicolai V.
Fehringer, Michaela
Innocenti, Gabriel
Vogl, Thomas
Article History
Received: 24 November 2023
Accepted: 12 June 2024
First Online: 29 July 2024
Declarations
:
: Ethical clearance for the study was obtained from the Institutional Review Board (IRB) of the UMCG (IRB no. 2008/338), adhering to the principles outlined in the Declaration of Helsinki (2013).
: Consent for publication is covered.
: A.R.B. has received a research grant from Janssen Pharmaceuticals and received speaker’s fees from AbbVie, outside the submitted work. All other authors declare that they have no competing interests.